의약품 아이솔레이터 시장 예측(-2030년) : 유형별, 시스템 유형별, 압력별, 구성별, 유통 채널별, 용도별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Pharmaceutical Isolator Market is accounted for $12.45 billion in 2023 and is expected to reach $24.82 billion by 2030 growing at a CAGR of 10.36% during the forecast period. Pharmaceutical isolators are employed as a barrier system that prevents contamination. Pharmaceutical isolators are used in a variety of industries, including microbiological testing, cell therapy processing, advanced pharmaceutical manufacturing (ATMP) and the weighing, packaging, and distribution of sterile injectable products.

According to the Pharmaceutical Research and Manufacturers of America data updates from September 2021, since 2000, PhRMA member companies have invested more than USD 1.1 Trillion in the search for new treatments and cures, including USD 102.3 Billion in 2021 alone.

Market Dynamics:

Driver:

Growing requirement for pharmacological sterile procedures

The increasing recognition of the vital role cleanliness plays in the production of pharmaceuticals is driving the demand for sterile pharmaceutical processes. Isolators become essential instruments as pharmaceutical companies work to provide the best possible drugs. Moreover, pharmaceutical products are kept pure and undamaged thanks to these carefully monitored settings that are outfitted with cutting-edge containment and air filtration systems.

Restraint:

Budgetary restrictions and upfront investment

Pharmaceutical isolators have many advantages, such as regulatory compliance and contamination control, but their installation is expensive up front. However, some pharmaceutical companies may find it difficult to afford the costs involved in designing, installing, and validating isolator systems, particularly smaller ones or those with more restricted funding. Despite the long-term benefits that isolators offer, this financial barrier may prevent widespread adoption.

Opportunity:

Technological developments in isolators

Pharmaceutical companies have a lot of potential thanks to ongoing advancements in isolator technology. Innovations that contribute to the development of isolator solutions include better containment systems, improved material designs, and more user-friendly interfaces. Moreover, businesses in the isolator technology sector that make research and development investments stand to benefit from a competitive advantage by providing cutting-edge solutions that solve existing issues and fit the changing demands of the market.

Threat:

Rising alternative technologies for containment

The dominant position of pharmaceutical isolators in the market is under threat from the emergence of alternative solutions in the dynamic landscape of containment technologies. For some applications, advanced barrier technologies, robotic systems, or alternatives to closed-system processing may be viable options that draw attention and funding away from conventional isolator solutions. Additionally, manufacturers of isolators must constantly innovate and highlight the distinctive value proposition of their goods in order to lessen this threat.

COVID-19 Impact:

The pharmaceutical isolator market has been impacted by the COVID-19 pandemic in many ways. The demand for pharmaceutical isolators has been fueled by the pandemic's increased focus on drug development and healthcare, but there have been obstacles due to workforce shortages, global supply chain disruptions, and uncertain economic conditions. Furthermore, the pandemic has highlighted the significance of flexible and agile manufacturing processes, leading businesses to reevaluate and improve their containment plans. This could spur innovation in the pharmaceutical isolator market in the aftermath of the pandemic.

The Floor standing segment is expected to be the largest during the forecast period

Due to its prominence in offering ample workspace and flexibility for a variety of manufacturing processes, the floor-standing segment holds the largest share of the pharmaceutical isolator market. With room for larger equipment and the ability to support ergonomic workflows, floor-standing isolators provide large spaces for intricate operations. Moreover, these are appropriate for a wide range of applications, including high-potency drug manufacturing and aseptic processing, due to their versatility. Complex control systems, material pass-through systems, and integrated glove ports are just a few examples of the advanced features that these isolators frequently incorporate.

The Contract Research Organizations segment is expected to have the highest CAGR during the forecast period

Contract Research Organizations (CROs) are the market segment with the highest CAGR. CROs are essential to the biotechnology and pharmaceutical industries because they offer specialized services for research and development. The need for sophisticated laboratory equipment, including cutting-edge diagnostic tools and instruments, has increased due to the trend of outsourcing drug development and clinical trials. Furthermore, CROs use academic institutions, research centers, and diagnostic labs to carry out extensive studies that promote the uptake of cutting-edge technologies.

Region with largest share:

Due to its strong healthcare system, large R&D expenditures, and strict regulatory requirements, North America presently commands the largest share of the market for pharmaceutical isolators. The numerous contract research organizations and the pharmaceutical and biotechnology companies that operate in the area have a significant impact on the demand for isolator systems. Moreover, a proactive approach to implementing state-of-the-art technologies and a strong focus on upholding the highest standards of product quality and safety add to the prevalence of pharmaceutical isolators in North America.

Region with highest CAGR:

The Asia-Pacific-Pacific has the highest CAGR in the market, driven by dynamic developments in the biotechnology and pharmaceutical industries. Increased investments in healthcare infrastructure, a growing focus on research and development, and a surge in drug development activities are all occurring in the region. Additionally, the market for pharmaceutical isolators is growing due to a number of factors, including a large patient population, rising healthcare costs, and a supportive regulatory framework.

Key players in the market

Some of the key players in Pharmaceutical Isolator market include: Getinge AB, Fedegari Autoclavi S.p.A, Azbil Corporation, Schematic Engineering Industries, Germfree Laboratories, Inc., Chiyoda Corporation, Hosokawa Micron B.V, Bioquell Inc., NuAire Inc, Hecht Technologie Gmbh, Comecer S.P.A, Skan AG, M. Braun Inertgas-Systeme Gmbh, Tema Sinergie S.P.A, Chamunda Pharma Machinery Pvt. Ltd and Isotech Design.

Key Developments:

In October 2023, Azbil Corporation has announced an investment agreement with Forest Energy Inc., headquartered in Tokyo. To support the realization of a sustainable society powered by renewable energy, Azbil is underwriting Forest Energy's third-party allocation of Renewable Energynew shares.

In October 2023, Germfree Laboratories and Title21 Health Solutions unveil a groundbreaking mobile manufacturing platform seamlessly integrated with an advanced manufacturing operating system, set to redefine decentralized point-of-care (POC) cell and gene therapy production. This partnership focuses on decentralized manufacturing, an innovative approach to traditional centralized models, aiming to overcome bottlenecks and streamline access to therapy delivery.

In May 2023, Getinge announces an agreement to acquire 100% of the shares in High Purity New England, Inc. a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications. This acquisition is another step in Getinge Life Science strategic journey to further expand our presence in the biopharma segment, says Eric Honroth, President Life Science at Getinge.

Types Covered:

• Aseptic Isolators
• Containment Isolators
• Bio Isolators
• Sampling And Weighing Isolators
• Active Pharmaceutical Ingredient (API) Manufacturing Isolators
• Radiopharmaceutical Isolators
• Fluid Dispensing Isolators
• Production Isolators
• Other Types

System Types Covered:

• Closed System
• Open System

Pressures Covered:

• Positive Pressure
• Negative Pressure

Configurations Covered:

• Floor Standing
• Modular
• Mobile
• Compact
• Table Top
• Portable
• Other Configuartions

Distribution Channels Covered:

• Direct Tender
• Retail Sales
• Third Party Distributors

Applications Covered:

• Sterility Testing
• Sampling/ Weighing/ Distribution
• Medical Device Manufacturing
• Other Applications

End Users Covered:

• Hospitals
• Diagnostic Laboratories
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Pharmaceutical Isolator Market, By Type

• 5.1 Introduction
• 5.2 Aseptic Isolators
• 5.3 Containment Isolators
• 5.4 Bio Isolators
• 5.5 Sampling And Weighing Isolators
• 5.6 Active Pharmaceutical Ingredient (API) Manufacturing Isolators
• 5.7 Radiopharmaceutical Isolators
• 5.8 Fluid Dispensing Isolators
• 5.9 Production Isolators
• 5.10 Other Types

6 Global Pharmaceutical Isolator Market, By System Type

• 6.1 Introduction
• 6.2 Closed System
• 6.3 Open System

7 Global Pharmaceutical Isolator Market, By Pressure

• 7.1 Introduction
• 7.2 Positive Pressure
• 7.3 Negative Pressure

8 Global Pharmaceutical Isolator Market, By Configuration

• 8.1 Introduction
• 8.2 Floor Standing
• 8.3 Modular
• 8.4 Mobile
• 8.5 Compact
• 8.6 Table Top
• 8.7 Portable
• 8.8 Other Configuartions

9 Global Pharmaceutical Isolator Market, By Distribution Channel

• 9.1 Introduction
• 9.2 Direct Tender
• 9.3 Retail Sales
• 9.4 Third Party Distributors

10 Global Pharmaceutical Isolator Market, By Application

• 10.1 Introduction
• 10.2 Sterility Testing
• 10.3 Sampling/ Weighing/ Distribution
• 10.4 Medical Device Manufacturing
• 10.5 Other Applications

11 Global Pharmaceutical Isolator Market, By End User

• 11.1 Introduction
• 11.2 Hospitals
• 11.3 Diagnostic Laboratories
• 11.4 Academic and Research Institutes
• 11.5 Pharmaceutical and Biotechnology Companies
• 11.6 Contract Research Organizations
• 11.7 Other End Users

12 Global Pharmaceutical Isolator Market, By Geography

• 12.1 Introduction
• 12.2 North America
  • 12.2.1 US
  • 12.2.2 Canada
  • 12.2.3 Mexico
• 12.3 Europe
  • 12.3.1 Germany
  • 12.3.2 UK
  • 12.3.3 Italy
  • 12.3.4 France
  • 12.3.5 Spain
  • 12.3.6 Rest of Europe
• 12.4 Asia Pacific
  • 12.4.1 Japan
  • 12.4.2 China
  • 12.4.3 India
  • 12.4.4 Australia
  • 12.4.5 New Zealand
  • 12.4.6 South Korea
  • 12.4.7 Rest of Asia Pacific
• 12.5 South America
  • 12.5.1 Argentina
  • 12.5.2 Brazil
  • 12.5.3 Chile
  • 12.5.4 Rest of South America
• 12.6 Middle East & Africa
  • 12.6.1 Saudi Arabia
  • 12.6.2 UAE
  • 12.6.3 Qatar
  • 12.6.4 South Africa
  • 12.6.5 Rest of Middle East & Africa

13 Key Developments

• 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 13.2 Acquisitions & Mergers
• 13.3 New Product Launch
• 13.4 Expansions
• 13.5 Other Key Strategies

14 Company Profiling

• 14.1 Getinge AB
• 14.2 Fedegari Autoclavi S.p.A
• 14.3 Azbil Corporation
• 14.4 Schematic Engineering Industries
• 14.5 Germfree Laboratories, Inc.
• 14.6 Chiyoda Corporation
• 14.7 Hosokawa Micron B.V
• 14.8 Bioquell Inc.
• 14.9 NuAire Inc
• 14.10 Hecht Technologie Gmbh
• 14.11 Comecer S.P.A
• 14.12 Skan AG
• 14.13 M. Braun Inertgas-Systeme Gmbh
• 14.14 Tema Sinergie S.P.A
• 14.15 Chamunda Pharma Machinery Pvt. Ltd
• 14.16 Isotech Design